Lifeward (LFWD) Total Non-Current Liabilities (2014 - 2026)
Lifeward (LFWD) posted Total Non-Current Liabilities of $16.5 million for Q1 2026, up 572.36% sequentially from $2.5 million in Q4 2025, and up 1186.51% YoY from $1.3 million in Q1 2025.
Lifeward (LFWD) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
Lifeward has reported Total Non-Current Liabilities for 13 years, with the latest figure at $16.5 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 1186.51% year-over-year to $16.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.5 million (up 1186.51% YoY) and the FY2025 annual result came in at $2.5 million, up 73.6% from the prior year.
- Total Non-Current Liabilities grew to $16.5 million in Q1 2026 per LFWD's latest filing, from $2.5 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $16.5 million in Q1 2026 and troughed at $961000.0 in Q3 2022.
- A 5-year average of $3.1 million and a median of $1.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities plunged 71.58% in 2025, then surged 1186.51% in 2026.
- Over 5 years, Total Non-Current Liabilities stood at $1.3 million in 2022, then soared by 279.13% to $4.9 million in 2023, then slumped by 71.09% to $1.4 million in 2024, then soared by 73.6% to $2.5 million in 2025, then soared by 572.36% to $16.5 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $16.5 million, $2.5 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Lifeward | 20.11 Mn | 10.66 Mn | 2.71 Mn | 11.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.49 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 4.33 Mn |
| Mar 31, 2024 | 4.51 Mn |
| Dec 31, 2023 | 4.89 Mn |
| Sep 30, 2023 | 4.63 Mn |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.58 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 961,000.00 |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 1.19 Mn |
| Dec 31, 2021 | 1.33 Mn |
| Sep 30, 2021 | 1.34 Mn |
| Jun 30, 2021 | 1.43 Mn |